Protective effects of Salvia officinalis extract against cyclophosphamide-induced genotoxicity and oxidative stress in rats

Medicinal plants, especially rich in polyphenolic compounds, have been suggested to be chemopreventive on account of antioxidative properties. Salvia officinalis L., an aromatic and medicinal plant, is widely used in folk medicine and is well known for its antioxidant properties. Therefore, the present study was designed to investigate the antioxidative, possible genotoxic, and antigenotoxic potency of S. officinalis extract against cyclophosphamide (CYP)-induced oxidative stress and genotoxicity in Wistar albino rats. Animals were orally dosed with S. officinalis extract (50, 100, and 150 mg/kg body weight) for 7 days before the administration of a single intraperitoneal dose of CYP (40 mg/kg body weight). The biochemical and cytogenetic determinations were carried out 24 h after CYP injection. The activities of malondialdehyde, superoxide dismutase, and catalase were determined in liver, kidney, and heart tissues. The frequency of micronucleated polychromatic erythrocytes (MNPCEs) and the ratio of polychromatic erythrocytes to normochromatic erythrocytes (PCE/NCE) were also evaluated. Additionally, the antioxidant capacity of the extract was analyzed. The micronucleus assay revealed that all doses of the extract tested presented no genotoxic activity; in addition, the 2 highest doses reduced the MNPCEs and increased the PCE/NCE ratio in the bone marrow and restored the oxidative stress markers in CYP-treated rats. In correlation with these findings, S. officinalis extract exhibited high antioxidant capacity. The results of the present study suggest that the methanolic extract of S. officinalis has a protective effect against CYP-induced oxidative stress and genotoxicity through its antioxidant property.

Protective effects of Salvia officinalis extract against cyclophosphamide-induced genotoxicity and oxidative stress in rats

Medicinal plants, especially rich in polyphenolic compounds, have been suggested to be chemopreventive on account of antioxidative properties. Salvia officinalis L., an aromatic and medicinal plant, is widely used in folk medicine and is well known for its antioxidant properties. Therefore, the present study was designed to investigate the antioxidative, possible genotoxic, and antigenotoxic potency of S. officinalis extract against cyclophosphamide (CYP)-induced oxidative stress and genotoxicity in Wistar albino rats. Animals were orally dosed with S. officinalis extract (50, 100, and 150 mg/kg body weight) for 7 days before the administration of a single intraperitoneal dose of CYP (40 mg/kg body weight). The biochemical and cytogenetic determinations were carried out 24 h after CYP injection. The activities of malondialdehyde, superoxide dismutase, and catalase were determined in liver, kidney, and heart tissues. The frequency of micronucleated polychromatic erythrocytes (MNPCEs) and the ratio of polychromatic erythrocytes to normochromatic erythrocytes (PCE/NCE) were also evaluated. Additionally, the antioxidant capacity of the extract was analyzed. The micronucleus assay revealed that all doses of the extract tested presented no genotoxic activity; in addition, the 2 highest doses reduced the MNPCEs and increased the PCE/NCE ratio in the bone marrow and restored the oxidative stress markers in CYP-treated rats. In correlation with these findings, S. officinalis extract exhibited high antioxidant capacity. The results of the present study suggest that the methanolic extract of S. officinalis has a protective effect against CYP-induced oxidative stress and genotoxicity through its antioxidant property.

___

  • Withrow, S.J., MacEwen, E.G.: Small Animal Clinical Oncology. 3rd edn., W.B. Saunders, Philadelphia, Pennsylvania, USA. 2001. 2. Kopecna, L.: Late eff ects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia. Bratisl. Lek. Listy., 2001; 102: 357–360.
  • Gustafsson, L.L, Eriksson, L.S., Dahl, M.L., Eleborg, L., Ericzon, B.G., Nyberg, A.: Cyclophosphamide-induced acute liver failure requiring transplantation in a patient with genetically defi cient debrisoquine metabolism: a causal relationship? J. Intern. Med., 1996; 240: 311–314.
  • Hales, B.F.: Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein. Cancer Res., 1982; 42: 3016–3021.
  • Madle, E., Korte, A., Beek, B.: Species diff erences in mutagenicity testing. II. Sister-chromatid exchange and micronucleus induction in rats, mice and Chinese hamsters treated with cyclophosphamide. Mutagenesis, 1986; 1: 419– 422.
  • Moore, F.R., Urda, G.A., Krishna, G., Th eiss, J.C.: An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen. 1. Studies with cyclophosphamide. Mutat. Res., 1995; 335: 191–199. 7. Manda, K., Bhatia, A.L.: Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biol. Toxicol., 2003; 19: 367–372.
  • Li, M., Zhu, Q., Hu, C., Giesy, J.P., Kong, Z., Cui, Y.: Protective eff ects of eicosapentaenoic acid on genotoxicity and oxidative stress of cyclophosphamide in mice. Environ. Toxicol., 2011; 26: 217–223. 9. Oboh, G., Henle, T.: Antioxidant and inhibitory eff ects of aqueous extracts of Salvia offi cinalis leaves on pro-oxidant- induced lipid peroxidation in brain and liver in vitro. J. Med. Food, 2009; 12: 77–84.
  • Todorova, V., Vanderpool, D., Blossom, S., Nwokedi, E., Hennings, L., Mrak, R., Klimberg, V.S.: Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione. Nutrition, 2009; 25: 812–817.
  • Grzegorczyk, I., Matkowski, A., Wysokinska, H.: Antioxidant activity of extracts from in vitro cultures of Salvia offi cinalis L. Food Chem., 2007; 104: 536–541.
  • Subapriya, R., Kumaragurupan, R., Abraham, S.K., Nagini, S.: Protective eff ects of ethanolic neem leaf extract on N-methyl-N’-nitro-N-nitrosoguanidine-induced genotoxicity and oxidative stress in mice. Drug Chem. Toxicol., 2004; 27: 15–26.
  • Weisburger, J.H.: Antimutagenesis and anticarcinogenesis, from the past to the future. Mutat. Res., 2001; 480-481: 23–35.
  • Gurib-Fakim, A.: Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol. Aspects Med., 2006; 27: 1–93.
  • Hedge, I.C.: Flora of Turkey and the East Aegean Islands. Edinburgh University Press, Edinburgh. 1982.
  • Mitić-Ćulafi ć, D., Vuković-Gačić, B., Knežević-Vukčević, J., Stanković, S., Simić, D.: Comparative study on the antibacterial activity of volatiles from sage (Salvia offi cinalis L.). Arch. Biol. Sci., 2005; 57: 173–178.
  • Longaray, A.P.D., Moschen-Pistorello, I.T., Artico, L., Atti- Serafi ni, L., Echeverrigaray, S.: Antibacterial activity of the essential oils of Salvia offi cinalis L. and Salvia triloba L. cultivated in South Brazil. Food Chem., 2007; 100: 603–608.
  • Šmidling, D., Mitić-Ćulafi ć, D., Vuković-Gačić, B., Simić, D., Knežević-Vukčević, J.: Evaluation of antiviral activity of fractionated extracts of sage Salvia offi cinalis L. Arch. Biol. Sci., 2008; 60: 421–429.
  • Baricevic, D., Sosa, S., Della, L.R., Tubaro, A., Simonovska, B., Krasna, A., Zupancic, A.: Topical anti-infl ammatory activity of Salvia offi cinalis L. leaves: the relevance of ursalic acid. J. Ethnopharmacol., 2001; 75: 125–132.
  • Eidi, M., Eidi, A., Zamanizadeh, H.: Eff ect of Salvia offi cinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J. Ethnopharmacol., 2005; 100: 310–313.
  • Bouaziz, M., Yangui, T., Sayadi, S., Dhouib, A.: Disinfectant properties of essential oils from Salvia offi cinalis L. cultivated in Tunisia. Food Chem. Toxicol., 2009; 47: 2755– 2760.
  • Vuković-Gačić, B., Nikčević, S., Berić-Bjedov, T., Knežević- Vukčević, J., Simić, D.: Antimutagenic eff ect of essential oil of sage (Salvia offi cinalis L.) and its monoterpenes against UV-induced mutations in Escherichia coli and Saccharomyces cerevisiae. Food Chem. Toxicol., 2006; 44: 1730–1738.
  • Xavier, C.P, Lima, C.F, Fernandes-Ferreira, M., Pereira- Wilson, C.: Salvia fruticosa, Salvia offi cinalis, and rosmarinic acid induce apoptosis and inhibit proliferation of human colorectal cell lines: the role in MAPK/ERK pathway. Nutr. Cancer, 2009; 61: 564–571.
  • Zupko, I., Hohmann, J., Redei, D., Falkay, G., Janicsak, G., Mathe, I.: Antioxidant activity of leaves of Salvia species in enzyme-dependent and enzyme-independent systems of lipid peroxidation and their phenolic constituents. Planta Med., 2001; 97: 383–389.
  • Cuvelier, M.E., Berset, C., Richard, H.: Antioxidant constituents in sage (Salvia offi cinalis). J. Agr. Food Chem., 1994; 42: 665–669.
  • Lima, C.F., Carvalho, F., Fernandes, E., Bastos, M.L., Santos- Gomes, P.C., Fernandes-Ferreira, M., Pereira-Wilson, C.: Evaluation of toxic/protective eff ects of the essential oil of Salvia offi cinalis on freshly isolated rat hepatocytes. Toxicol. in Vitro, 2004; 18: 457–465.
  • Lu, Y., Foo, L.Y.: Antioxidant activities of polyphenols from sage (Salvia offi cinalis). Food Chem., 2001; 75: 197–202.
  • Th en, M., Lemberkovics, E., Marczal, G., Szentmihályi, K., Szöke, E.: Plant anatomical and phytochemical evaluation of Salvia species. Acta Pharm. Hung., 1998; 68: 163–174.
  • Capek, P., Machová, E., Turjan, J.: Scavenging and antioxidant activities of immunomodulating polysaccharides isolated from Salvia offi cinalis L. Int. J. Biol. Macromol., 2009; 44: 75–80.
  • Lima, C.F., Valentao, P.C., Andrade, P.B., Seabra, R.M., Fernandes-Ferreira, M., Pereira-Wilson, C.: Water and methanolic extracts of Salvia offi cinalis protect HepG2 cells from t-BHP induced oxidative damage. Chem. Biol. Interact., 2007; 167: 107–115.
  • Krishna, G., Kropko, M.L., Ciaravino, V., Th eiss, J.C.: Simultaneous micronucleus and chromosome aberration assessment in the rat. Mutat. Res., 1991; 264: 29–35.
  • Özyürek, M., Bektaşoğlu, B., Güçlü, K., Güngör, N., Apak, R.: Simultaneous total antioxidant capacity assay of lipophilic and hydrophilic antioxidants in the same acetone–water solution containing 2% methyl-β-cyclodextrin using the cupric reducing antioxidant capacity (CUPRAC) method. Anal. Chim. Acta, 2008; 630: 28–39.
  • Dweck, C.A.: Th e folklore and cosmetic use of various Salvia species.. In: Kintzios, S.E., Ed. Sage: Th e Genus Salvia. Harwood Academic Publishers, Amsterdam. 2000; 1–25.
  • Schmid, W.: Th e micronucleus test. Mutat. Res., 1975; 31: 9–15.
  • MacGregor, T.J., Heddle, A.J., Hite, M., Margolin, H.B., Ramel, C., Salamone, F.M.: Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes. Mutat. Res., 1987; 189: 103–112.
  • Yoshoiko, T., Kawada, K., Shimada, T.: Lipid peroxidation in maternal and cord blood and protective mechanism against active-oxygen toxicity in the blood. Am. J. Obstet. Gynecol., 1979; 135: 372–376.
  • Sun, Y., Oberley, L.W., Li, Y.: A simple method for clinical assay of superoxide dismutase. Clin. Chem., 1988; 34: 497– 500.
  • Durak, I., Yurtarslani, Z., Canbolat, O., Akyol, O.: A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin. Chim. Acta, 1993; 31: 103–104.
  • Aebi, H.: Catalase. In: Bergmeyer, H.U., Ed. Methods in Enzymatic Analysis. Academic Press, New York. 1983; 276–286.
  • Lowry, O.H, Rosebrough, N.J., Farr, A.L.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951; 193: 265–275.
  • Apak, R., Güçlü, K., Özyürek, M., Karademir, S.E.: Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method. J. Agric. Food Chem., 2004; 52: 7970–7981.
  • Elhajouji, A., Santos, A.P., Van Hummelen, P., Kirsch- Volders, M.: Metabolic diff erences between whole blood and isolated lymphocyte cultures for micronucleus (MN) induction by cyclophosphamide and benzo[a]pyrene. Mutagenesis, 1994; 9: 307–313.
  • Sorsa, M., Pyy, L., Salomaa, S., Nylund, L., Yager, J.W.: Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals. Mutat. Res., 1988; 204: 465–479.
  • Crook, T.R., Souhami, R.L., McLean, A.E.: Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells. Cancer Res., 1986; 46: 5029–5034.
  • Bryce, S.M., Shi, J., Nicolette, J., Diehl, M., Sonders, P., Avlasevich, S., Raja, S., Bemis, J.C., Dertinger, S.D.: High content fl ow cytometric micronucleus scoring method is applicable to attachment cell lines. Environ. Mol. Mutagen., 2010; 51: 260–266.
  • Tripathi, D.N., Jena, G.B.: Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: a study in mice. Chem. Biol. Interact., 2009; 180: 398–406.
  • Patel, J.M., Block, E.R.: Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp. Lung Res., 1985; 8: 153–165.
  • Zhang, Q.H., Wu, C.F., Duan, L., Yang, J.Y.: Protective eff ects of ginsenoside Rg3 against cyclophosphamide- induced DNA damage and cell apoptosis in mice. Arch. Toxicol., 2008; 82: 117–123.
  • Aardema, M.J., Kirsch-Volders, M.: Th e in vitro micronucleus assay. In: Choy, W.N., Ed. Genetic Toxicology and Cancer Risk Assessment. Informa Healthcare, New York. 2001; 163–186.
  • Hayashi, M., Tice, R.R., MacGregor, J.T., Anderson, D., Blakey, D.H., Kirsh-Volders, M., Oleson, F.B., Pacchierotti, F., Romagna, F., Shimada, H., Sutou, S., Vannier, B.: In vivo rodent erythrocyte micronucleus assay. Mutat. Res., 1994; 312: 293–304.
  • Suzuki, Y., Nagae, Y., Li, J., Sakaba, H., Mozawa, K., Takahashi, A., Shimizu, H.: Th e micronucleus test and erythropoiesis. Eff ects of erythropoietin and a mutagen on the ratio of polychromatic to normochromatic erythrocytes (P/N ratio). Mutagenesis, 1989; 4: 420–424.
  • Chandrasekar, M.J.N., Bommu, P., Nanjan, M.J., Suresh, B.: Chemoprotective eff ect of Phyllanthus maderaspatensis in modulating cisplatin-induced nephrotoxicity and genotoxicity. Pharm. Biol., 2006; 44: 100–106.
  • SivaKumar, V., Niranjali Devaraj, S.: Protective eff ect of Plumbago zeylanica against cyclophosphamide-induced genotoxicity and oxidative stress in Swiss albino mice. Drug Chem. Toxicol., 2006; 29: 279–288.
  • El-Ashmawy1, I.M., El-Nahas, A.F., Salama, O.M.: Grape seed extract prevents gentamicin-induced nephrotoxicity and genotoxicity in bone marrow cells of mice. Basic Clin. Pharmacol., 2006; 99: 230–236.
  • Jahangir, T., Khan, T.H., Prasad, L., Sultana, S. Alleviation of free radical mediated oxidative and genotoxic eff ects of cadmium by farnesol in Swiss albino mice. Redox Rep., 2005; 10: 303–310.
  • Kehrer, J.P.: Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol., 1993; 23: 21–48.
  • Selvakumar, E., Prahalathan, C., Mythili, Y., Varalakshmi, P.: Protective eff ect of DL-α-lipoic acid in cyclophosphamide induced oxidative injury in rat testis. Reprod. Toxicol., 2004; 19: 163–167.
  • Lin, H.M., Yen, F.L., Ng, L.T., Lin, C.C.: Protective eff ects of Ligustrum lucidum fruit extract on acute butylated hydroxytoluene-induced oxidative stress in rats. J. Ethnopharmacol., 2007; 111: 129–136.
  • Senthilkumar, S., Yogeeta, S.K., Subashini, R., Devaki, T.: Attenuation of cyclophosphamide induced toxicity by squalene in experimental rats. Chem-Biol. Interact., 2006; 160: 252–260.
  • Premkumar, K., Abraham, S.K., Santhiya, S.T., Ramesh, A.: Protective eff ect of Spirulina fusiformis on chemical- induced genotoxicity in mice. Fitoterapia, 2004; 75: 24–31.
  • Santos-Gomes, P.C., Seabra, R.M., Andrade, P.B., Fernandes-Ferreira, M.: Phenolic antioxidant compounds produced by in vitro shoots of sage (Salvia offi cinalis L.). Plant Sci., 2002; 162: 981–987.
  • Roman, G.P., Neagu, E., Radu, G.L. Antiradical activities of Salvia offi cinalis and Viscum album L. extracts concentrated by ultrafi ltration process. Acta Sci. Pol. Technol. Aliment., 2009; 8: 47–58.
  • Patenkovic, A., Stamenkovic-Radak, M., Banjanac, T., Andjelkovic, M.: Antimutagenic eff ect of sage tea in the wing spot test of Drosophila melanogaster. Food Chem. Tox., 2009; 47: 180–183.
Turkish Journal of Veterinary and Animal Sciences-Cover
  • ISSN: 1300-0128
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Comparison of different lactation curve models in Sahiwal cows

Vilas DONGRE, Ravindar Singh GANDHI, Avtar SINGH

Molecular and kinetic characterization of lactate dehydrogenase enzyme in the heart and breast muscle of Japanese quail (Coturnix japonica)

Ram Pratap SINGH, Kochiganti Venkata Hanumat SASTRY, Radha AGARWAL, Nitin Kumar PANDEY, Vishesh Kumar SAXENA, Jag MOHAN

Establishment and biological research of the Jining Grey goat fibroblast line

Chunyu BAI, Dianjun WANG, Xiaohua SU, Minghai ZHANG, Weijun GUAN, Yuehui MA

Effects of dietary inclusion of clinoptilolite in colostrum and milk on certain haematological parameters of calves

Konstantinos POURLIOTIS, Maria KARATZIA, Efterpi CHRISTAKI

Effect of cold storage period on the quality of ram cauda epididymal spermatozoa recovered postmortem

Suhail Salam MIR, Farooz Ahmad LONE, Mohammad Zaffarullah KHAN, Asloob Ahmad MALIK, Rafiqul ISLAM, Khursheed Ahmad SOFI

Evaluation of the possibility of using oligosaccharide-free pea in Japanese quail nutrition

Danuta SZCZERBINSKA, Zofia TARASEWICZ, Piotr GULEWICZ

Effects of dietary protein supplementation on the performance of West African dwarf (WAD) goats infected with Haemonchus contortus and Trichostrongylus colubriformis

Linus İorundu MHOMGA, Pius Ajanwachukwu NNADI, Samuel Nnegbo CHIEJINA, İdika Kalu IDIKA, Lucas Atehmengo NGONGEH

First record of abnormal pigmentation in a wild common sole, Solea solea L., from the Aegean Sea

Okan AKYOL, Halil ŞEN

Prevention of predicted neonatal isoerythrolysis with jaundice foal agglutination test in a newborn foal

Aykut Göktürk ÜNER, Güney KAYA, Aydın OLTU

Saeid AMIRDAHRI, Hossein JANMOHAMMADI, Akbar TAGHIZADEH, Abbas RAFAT